Abstract:Aims: Ischemic stroke has become one of the main causes of death worldwide. MicroRNAs (miRNAs) have been implicated in cerebral ischemia-reperfusion (I/R) injury and could serve as therapeutic targets. 5-Lipoxygenase (5-LOX) is a key enzyme in the biosynthesis of leukotrienes and has been implicated in inflammatory central nerve system disorders. The objective of this study was to explore the neuroprotective effects of miR-193b-3p against focal cerebral I/R injury in rats by regulating 5-LOX expression. Methods and materials: Adult male Sprague-Dawley rats were subjected to transient middle cerebral artery occlusion and reperfusion injury. The level of miR-193b-3p expression was observed in the rat cortical peri-infarct region after focal cerebral I/R injury. Bioinformatics analysis was used to predict the binding sites of miR-193b-3p, and a dual-luciferase reporter gene assay was applied to verify the potential interaction between 5-LOX mRNA and miR-193b-3p. Then, rats were injected with a miR-193b-3p agomir (modified and enhanced mimic) or antagomir (modified and enhanced inhibitor) in the right lateral ventricle of the brain. Neurological deficit scores, infarct volumes, neuron damage and 5-LOX enzymatic activity and expression were measured. In an in vitro experiment, cultured PC12 cells were exposed to oxygen-glucose deprivation and reperfusion (OGD/R). OGD/R-induced cells were treated with a miR-193b-3p mimic or inhibitor and 5-LOX siRNA. Cell viability, lactate dehydrogenase release, apoptosis rate and 5-LOX expression were evaluated. Results: The level of miR-193b-3p expression was increased in the cortical peri-infarct region of rats with cerebral focal I/R injury. The results of the dual-luciferase reporter gene assay showed that a miR-193b-3p binding site was located in the 3' untranslated region (3'UTR) of 5-LOX mRNA. Neurological deficit scores, infarct volumes and neuronal injury were alleviated by miR-193b-3p agomir treatment but aggravated by miR-193b-3p antagomir. Furthermore, leukotriene B4, cysteinyl-leukotrienes and 5-LOX expression in the cortical peri-infarct region of rats with focal cerebral I/R injury were also downregulated by miR-193b-3p agomir treatment but upregulated by miR-1936-3p antagomir. In PC12 cells, miR-193b-3p mimic significantly decreased OGD/Rinduced cell death and reduced lactate dehydrogenase release and 5-LOX expression. In contrast, miR-193b-3p inhibitor exacerbated OGD/R-induced injury in PC12 cells. Additionally, the in vitro effects of miR-193b-3p inhibitor on OGD/R-induced cell injury were partially reversed by 5-LOX siRNA treatment. Conclusion: MiR-193b-3p has a potentially neuroprotective effect on focal cerebral I/R-induced injury by inhibiting 5-LOX expression.

MicroRNA-532-5p Protects Against Cerebral Ischemia-Reperfusion Injury by Directly Targeting CXCL1.

MiR-27a-3p Suppresses Cerebral Ischemia-Reperfusion Injury by Targeting FOXO1.

Retracted: Protective Effects of Microrna‐431 Against Cerebral Ischemia‐reperfusion Injury in Rats by Targeting the Rho/Rho‐kinase Signaling Pathway

MicroRNAs Expression and Function in Cerebral Ischemia Reperfusion Injury

MiRNA-34c-5p protects against cerebral ischemia/reperfusion injury: involvement of anti-apoptotic and anti-inflammatory activities

Mir-211-5p Alleviates Focal Cerebral Ischemia-Reperfusion Injury in Rats by Down-Regulating the Expression of COX2.

Mir-155 Knockdown Protects Against Cerebral Ischemia and Reperfusion Injury by Targeting MafB.

Mir-155-5p Accelerates Cerebral Ischemia-Reperfusion Inflammation Injury and Cell Pyroptosis Via DUSP14/ TXNIP/NLRP3 Pathway.

Inhibition of miR-19a-3p decreases cerebral ischemia/reperfusion injury by targeting IGFBP3 in vivo and in vitro

microRNA-455-5p alleviates neuroinflammation in cerebral ischemia/reperfusion injury.

Microrna-455-5p Alleviates Neuroinflammation in Cerebral Ischemia/reperfusion Injury

MicroRNA-32-5p attenuates cerebral ischemia/reperfusion injuries by modulating the phosphatase and tensin homologous protein

MicroRNA-193b-3p Alleviates Focal Cerebral Ischemia and Reperfusion-Induced Injury in Rats by Inhibiting 5-Lipoxygenase Expression

MicroRNA-182-5p Attenuates Cerebral Ischemia-Reperfusion Injury by Targeting Toll-like Receptor 4

Inhibition of miR-423-5p exerts neuroprotective effects in an experimental rat model of cerebral ischemia/reperfusion injury

miR-103a-3p alleviates oxidative stress, apoptosis, and immune disorder in oxygen-glucose deprivation-treated BV2 microglial cells and rats with cerebral ischemia-reperfusion injury by targeting high mobility group box 1

Overexpression of microRNA-202-3p in bone marrow mesenchymal stem cells improves cerebral ischemia-reperfusion injury by promoting angiogenesis and inhibiting inflammation

MicroRNA-193b-3p reduces oxidative stress and mitochondrial damage in rats with cerebral ischemia-reperfusion injury via the seven in absentia homolog 1/Jun N-terminal kinase pathway

MicroRNA-26b-5p alleviates cerebral ischemia-reperfusion injury in rats via inhibiting the N-myc/PTEN axis by downregulating KLF10 expression

Suppression of microRNA-320 Induces Cerebral Protection Against Ischemia/Reperfusion Injury by Targeting HMGB1/NF-kappaB Axis.

Up-regulation of Mir-499A-5p Decreases Cerebral Ischemia/reperfusion Injury by Targeting PDCD4